Skip to main content
Anand Rohatgi, MD, Cardiology, Dallas, TX

AnandKumarRohatgiMDMSCS, FACC, FAHA

Cardiology Dallas, TX

Preventive Cardiology

Professor of Medicine / Preventive Cardiology / Cardiovascular Disease Fellowship Assistant Program Director of Academic Development

Dr. Rohatgi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rohatgi's full profile

Already have an account?

  • Office

    2001 Inwood Rd
    Fl 5
    Dallas, TX 75390
    Phone+1 214-645-8000

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 2005 - 2008
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2002 - 2005
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2007 - 2026
  • PA State Medical License
    PA State Medical License 2002 - 2008

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Value of Coronary Artery Calcium Scanning in Association with the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease  
    Ezimamaka Ajufo, Anand Rohatgi, JAMA Cardiology

Press Mentions

  • SAHELI: Do Culturally Adapted Lifestyle Intervention Improve CVD Risk Factors?
    SAHELI: Do Culturally Adapted Lifestyle Intervention Improve CVD Risk Factors?September 26th, 2024
  • Antibodies Associated with Rare Disorder May Signal Future Risk of Heart Attack and Stroke
    Antibodies Associated with Rare Disorder May Signal Future Risk of Heart Attack and StrokeMay 15th, 2023
  • High HDL-C Levels Linked to Increased Fracture Risk
    High HDL-C Levels Linked to Increased Fracture RiskJanuary 26th, 2023
  • Join now to see all

Grant Support

  • Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular DiseaseNIH/NHLBI2019–2024
  • The Genetic and Molecular Basis of Cholesterol EffluxNIH/NHLBI2018–2023

Professional Memberships